|
1
|
Alexander RP, Fang G, Rozowsky J, Snyder M
and Gerstein MB: Annotating non-coding regions of the genome. Nat
Rev Genet. 11:559–571. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ponting CP and Belgard TG: Transcribed
dark matter: Meaning or myth? Hum Mol Genet. 19(R2): R162–R168.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Carninci P, Kasukawa T, Katayama S, Gough
J, Frith MC, Maeda N, Oyama R, Ravasi T, Lenhard B, Wells C, et al
RIKEN Genome Exploration Research Group and Genome Science Group
(Genome Network Project Core Group): The transcriptional landscape
of the mammalian genome. Science. 309:1559–1563. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hammond SM: MicroRNAs as tumor
suppressors. Nat Genet. 39:582–583. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Amaral PP, Dinger ME, Mercer TR and
Mattick JS: The eukaryotic genome as an RNA machine. Science.
319:1787–1789. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Inagaki S, Numata K, Kondo T, Tomita M,
Yasuda K, Kanai A and Kageyama Y: Identification and expression
analysis of putative mRNA-like non-coding RNA in Drosophila. Genes
Cells. 10:1163–1173. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Derrien T, Johnson R, Bussotti G, Tanzer
A, Djebali S, Tilgner H, Guernec G, Martin D, Merkel A, Knowles DG,
et al: The GENCODE v7 catalog of human long noncoding RNAs:
Analysis of their gene structure, evolution, and expression. Genome
Res. 22:1775–1789. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jonsson P, Coarfa C, Mesmar F, Raz T,
Rajapakshe K, Thompson JF, Gunaratne PH and Williams C:
Single-Molecule Sequencing Reveals Estrogen-Regulated Clinically
Relevant lncRNAs in Breast Cancer. Mol Endocrinol. 29:1634–1645.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ylipää A, Kivinummi K, Kohvakka A, Annala
M, Latonen L, Scaravilli M, Kartasalo K, Leppänen SP, Karakurt S,
Seppälä J, et al: Transcriptome Sequencing Reveals PCAT5 as a Novel
ERG-Regulated Long Noncoding RNA in Prostate Cancer. Cancer Res.
75:4026–4031. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wapinski O and Chang HY: Long noncoding
RNAs and human disease. Trends Cell Biol. 21:354–361. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zappulla DC and Cech TR: Yeast telomerase
RNA: A flexible scaffold for protein subunits. Proc Natl Acad Sci U
S A. 101:10024–10029. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Monnier P, Martinet C, Pontis J, Stancheva
I, Ait-Si-Ali S and Dandolo L: H19 lncRNA controls gene expression
of the Imprinted Gene Network by recruiting MBD1. Proc Natl Acad
Sci U S A. 110:20693–20698. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Caley DP, Pink RC, Trujillano D and Carter
DR: Long noncoding RNAs, chromatin, and development.
ScientificWorldJournal. 10:90–102. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cheetham SW, Gruhl F, Mattick JS and
Dinger ME: Long noncoding RNAs and the genetics of cancer. Br J
Cancer. 108:2419–2425. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wilusz JE, Sunwoo H and Spector DL: Long
noncoding RNAs: Functional surprises from the RNA world. Genes Dev.
23:1494–1504. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pandey GK, Mitra S, Subhash S, Hertwig F,
Kanduri M, Mishra K, Fransson S, Ganeshram A, Mondal T, Bandaru S,
et al: The risk-associated long noncoding RNA NBAT-1 controls
neuroblastoma progression by regulating cell proliferation and
neuronal differentiation. Cancer Cell. 25:722–737. 2014. View Article : Google Scholar
|
|
20
|
Guttman M, Amit I, Garber M, French C, Lin
MF, Feldser D, Huarte M, Zuk O, Carey BW, Cassady JP, et al:
Chromatin signature reveals over a thousand highly conserved large
non-coding RNAs in mammals. Nature. 458:223–227. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang M, Gu H, Xu W and Zhou X:
Down-regulation of lncRNA MALAT1 reduces cardiomyocyte apoptosis
and improves left ventricular function in diabetic rats. Int J
Cardiol. 203:214–216. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jiang HJ, Wang S and Ding Y: Emerging
paradigms of long non-coding RNAs in gastrointestinal cancer. Am J
Stem Cells. 3:63–73. 2014.PubMed/NCBI
|
|
23
|
Zhang H, Zeitz MJ, Wang H, Niu B, Ge S, Li
W, Cui J, Wang G, Qian G, Higgins MJ, et al: Long noncoding
RNA-mediated intra-chromosomal interactions promote imprinting at
the Kcnq1 locus. J Cell Biol. 204:61–75. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Feng J, Bi C, Clark BS, Mady R, Shah P and
Kohtz JD: The Evf-2 noncoding RNA is transcribed from the Dlx-5/6
ultraconserved region and functions as a Dlx-2 transcriptional
coactivator. Genes Dev. 20:1470–1484. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Martianov I, Ramadass A, Serra Barros A,
Chow N and Akoulitchev A: Repression of the human dihydrofolate
reductase gene by a non-coding interfering transcript. Nature.
445:666–670. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang X, Arai S, Song X, Reichart D, Du K,
Pascual G, Tempst P, Rosenfeld MG, Glass CK and Kurokawa R: Induced
ncRNAs allosterically modify RNA-binding proteins in cis to inhibit
transcription. Nature. 454:126–130. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hollander MC, Alamo I and Fornace AJ Jr: A
novel DNA damage-inducible transcript, gadd7, inhibits cell growth,
but lacks a protein product. Nucleic Acids Res. 24:1589–1593. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu X, Li D, Zhang W, Guo M and Zhan Q:
Long non-coding RNA gadd7 interacts with TDP-43 and regulates Cdk6
mRNA decay. EMBO J. 31:4415–4427. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Faghihi MA, Modarresi F, Khalil AM, Wood
DE, Sahagan BG, Morgan TE, Finch CE, St Laurent G III, Kenny PJ and
Wahlestedt C: Expression of a noncoding RNA is elevated in
Alzheimer's disease and drives rapid feed-forward regulation of
beta-secretase. Nat Med. 14:723–730. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Faghihi MA, Zhang M, Huang J, Modarresi F,
Van der Brug MP, Nalls MA, Cookson MR, St-Laurent G III and
Wahlestedt C: Evidence for natural antisense transcript-mediated
inhibition of microRNA function. Genome Biol. 11:R562010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yoon JH, Abdelmohsen K and Gorospe M:
Posttranscriptional gene regulation by long noncoding RNA. J Mol
Biol. 425:3723–3730. 2013. View Article : Google Scholar :
|
|
32
|
Kandalepas PC and Vassar R: The normal and
pathologic roles of the Alzheimer's β-secretase, BACE1. Curr
Alzheimer Res. 11:441–449. 2014. View Article : Google Scholar
|
|
33
|
Kandalepas PC, Sadleir KR, Eimer WA, Zhao
J, Nicholson DA and Vassar R: The Alzheimer's β-secretase BACE1
localizes to normal presynaptic terminals and to dystrophic
presynaptic terminals surrounding amyloid plaques. Acta
Neuropathol. 126:329–352. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Berger SL, Kouzarides T, Shiekhattar R and
Shilatifard A: An operational definition of epigenetics. Genes Dev.
23:781–783. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Huang Y, Nayak S, Jankowitz R, Davidson NE
and Oesterreich S: Epigenetics in breast cancer: What's new? Breast
Cancer Res. 13:2252011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bernstein BE, Meissner A and Lander ES:
The mammalian epigenome. Cell. 128:669–681. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shen H and Laird PW: Interplay between the
cancer genome and epigenome. Cell. 153:38–55. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Costa FF: Epigenomics in cancer
management. Cancer Manag Res. 2:255–265. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cao J: The functional role of long
non-coding RNAs and epigenetics. Biol Proced Online. 16:112014.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu Y, Wang B, Liu X, Lu L, Luo F, Lu X,
Shi L, Xu W and Liu Q: Epigenetic silencing of p21 by long
non-coding RNA HOTAIR is involved in the cell cycle disorder
induced by cigarette smoke extract. Toxicol Lett. 240:60–67. 2016.
View Article : Google Scholar
|
|
41
|
Guil S and Esteller M: DNA methylomes,
histone codes and miRNAs: Tying it all together. Int J Biochem Cell
Biol. 41:87–95. 2009. View Article : Google Scholar
|
|
42
|
Sehgal L, Mathur R, Braun FK, Wise JF,
Berkova Z, Neelapu S, Kwak LW and Samaniego F: FAS-antisense 1
lncRNA and production of soluble versus membrane Fas in B-cell
lymphoma. Leukemia. 28:2376–2387. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Brannan CI, Dees EC, Ingram RS and
Tilghman SM: The product of the H19 gene may function as an RNA.
Mol Cell Biol. 10:28–36. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Moran VA, Perera RJ and Khalil AM:
Emerging functional and mechanistic paradigms of mammalian long
non-coding RNAs. Nucleic Acids Res. 40:6391–6400. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kong L, Zhou X, Wu Y, Wang Y, Chen L, Li
P, Liu S, Sun S, Ren Y, Mei M, et al: Targeting HOTAIR induces
mitochondria related apoptosis and inhibits tumor growth in head
and neck squamous cell carcinoma in vitro and in vivo. Curr Mol
Med. 15:952–960. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Cai X, Liu Y, Yang W, Xia Y, Yang C, Yang
S and Liu X: Long noncoding RNA MALAT1 as a potential therapeutic
target in osteo-sarcoma. J Orthop Res Nov. 17:2015.Epub ahead of
print.
|
|
47
|
Zhu YP, Bian XJ, Ye DW, Yao XD, Zhang SL,
Dai B, Zhang HL and Shen YJ: Long noncoding RNA expression
signatures of bladder cancer revealed by microarray. Oncol Lett.
7:1197–1202. 2014.PubMed/NCBI
|
|
48
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Burnett RA, Swanson Beck J, Howatson SR,
Lee FD, Lessells AM, McLaren KM, Ogston S, Robertson AJ, Simpson JG
and Smith GD: Observer variability in histopathological reporting
of malignant bronchial biopsy specimens. J Clin Pathol. 47:711–713.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Rivera MP, Detterbeck F and Mehta AC;
American College of Chest Physicians: Diagnosis of lung cancer: The
guidelines. Chest. 123(Suppl): 129S–136S. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Schreiber G and McCrory DC: Performance
characteristics of different modalities for diagnosis of suspected
lung cancer. summary of published evidence.
|
|
52
|
Li Y and Wei S: Advances on mechanisms of
coagulation with non-small cell lung cancer. Chin J Lung Can.
16:676–680. 2013.In Chinese.
|
|
53
|
Ji P, Diederichs S, Wang W, Böing S,
Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, et
al: MALAT-1, a novel noncoding RNA, and thymosin beta4 predict
metastasis and survival in early-stage non-small cell lung cancer.
Oncogene. 22:8031–8041. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Schmidt LH, Spieker T, Koschmieder S,
Schaffers S, Humberg J, Jungen D, Bulk E, Hascher A, Wittmer D,
Marra A, et al: The long noncoding MALAT-1 RNA indicates a poor
prognosis in non-small cell lung cancer and induces migration and
tumor growth. J Thorac Oncol. 6:1984–1992. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Shen L, Chen L, Wang Y, Jiang X, Xia H and
Zhuang Z: Long noncoding RNA MALAT1 promotes brain metastasis by
inducing epithelial-mesenchymal transition in lung cancer. J
Neurooncol. 121:101–108. 2015. View Article : Google Scholar
|
|
56
|
Wang G, Liu C, Deng S, Zhao Q, Li T, Qiao
S, Shen L, Zhang Y, Lü J, Meng L, et al: Long noncoding RNAs in
regulation of human breast cancer. Brief Funct Genomics. Nov
18–2015.Epub ahead of print. View Article : Google Scholar
|
|
57
|
Lei B, Xu SP, Liang XS, Li YW, Zhang JF,
Zhang GQ and Pang D: Long non-coding RNA MVIH is associated with
poor prognosis and malignant biological behavior in breast cancer.
Tumour Biol. Nov 10–2015.Epub ahead of print.
|
|
58
|
Rinn JL, Kertesz M, Wang JK, Squazzo SL,
Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, et al:
Functional demarcation of active and silent chromatin domains in
human HOX loci by noncoding RNAs. Cell. 129:1311–1323. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Tsai MC, Spitale RC and Chang HY: Long
intergenic noncoding RNAs: New links in cancer progression. Cancer
Res. 71:3–7. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Tsai MC, Manor O, Wan Y, Mosammaparast N,
Wang JK, Lan F, Shi Y, Segal E and Chang HY: Long noncoding RNA as
modular scaffold of histone modification complexes. Science.
329:689–693. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Liu YW, Sun M, Xia R, Zhang EB, Liu XH,
Zhang ZH, Xu TP, De W, Liu BR and Wang ZX: LincHOTAIR
epigenetically silences miR34a by binding to PRC2 to promote the
epithelial-to-mesenchymal transition in human gastric cancer. Cell
Death Dis. 6:e18022015. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Karytinos A, Forneris F, Profumo A,
Ciossani G, Battaglioli E, Binda C and Mattevi A: A novel mammalian
flavin-dependent histone demethylase. J Biol Chem. 284:17775–17782.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Sørensen KP, Thomassen M, Tan Q, Bak M,
Cold S, Burton M, Larsen MJ and Kruse TA: Long non-coding RNA
HOTAIR is an independent prognostic marker of metastasis in
estrogen receptor-positive primary breast cancer. Breast Cancer Res
Treat. 142:529–536. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Bhan A, Hussain I, Ansari KI, Kasiri S,
Bashyal A and Mandal SS: Antisense transcript long noncoding RNA
(lncRNA) HOTAIR is transcriptionally induced by estradiol. J Mol
Biol. 425:3707–3722. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Shi Y, Lu J, Zhou J, Tan X, He Y, Ding J,
Tian Y, Wang L and Wang K: Long non-coding RNA Loc554202 regulates
proliferation and migration in breast cancer cells. Biochem Biophys
Res Commun. 446:448–453. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Augoff K, McCue B, Plow EF and
Sossey-Alaoui K: miR-31 and its host gene lncRNA LOC554202 are
regulated by promoter hyper-methylation in triple-negative breast
cancer. Mol Cancer. 11:52012. View Article : Google Scholar
|
|
68
|
Ren S, Liu Y, Xu W, Sun Y, Lu J, Wang F,
Wei M, Shen J, Hou J, Gao X, et al: Long noncoding RNA MALAT-1 is a
new potential therapeutic target for castration resistant prostate
cancer. J Urol. 190:2278–2287. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Prensner JR, Iyer MK, Balbin OA,
Dhanasekaran SM, Cao Q, Brenner JC, Laxman B, Asangani IA, Grasso
CS, Kominsky HD, et al: Transcriptome sequencing across a prostate
cancer cohort identifies PCAT-1, an unannotated lincRNA implicated
in disease progression. Nat Biotechnol. 29:742–749. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Walsh AL, Tuzova AV, Bolton EM, Lynch TH
and Perry AS: Long noncoding RNAs and prostate carcinogenesis: the
missing 'linc'? Trends in molecular medicine. 2014 Aug;20(8):
428–36. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Martens-Uzunova ES, Bottcher R, Croce CM,
Jenster G, Visakorpi T and Calin GA: Long noncoding RNA in
prostate, bladder, and kidney cancer. European urology. 2014
Jun;65(6): 1140–51. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Crawford ED, Rove KO, Trabulsi EJ, Qian J,
Drewnowska KP, Kaminetsky JC, Huisman TK, Bilowus ML, Freedman SJ,
Glover WL Jr and Bostwick DG: Diagnostic performance of PCA3 to
detect prostate cancer in men with increased prostate specific
antigen: A prospective study of 1,962 cases. J Urol. 188:1726–1731.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Hessels D, Klein Gunnewiek JM, van Oort I,
Karthaus HF, van Leenders GJ, van Balken B, Kiemeney LA, Witjes JA
and Schalken JA: DD3(PCA3)-based molecular urine analysis for the
diagnosis of prostate cancer. Eur Urol. 44:8–15. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Crea F, Watahiki A, Quagliata L, Xue H,
Pikor L, Parolia A, Wang Y, Lin D, Lam WL, Farrar WL, et al:
Identification of a long non-coding RNA as a novel biomarker and
potential therapeutic target for metastatic prostate cancer.
Oncotarget. 5:764–774. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Miyoshi N, Wagatsuma H, Wakana S,
Shiroishi T, Nomura M, Aisaka K, Kohda T, Surani MA, Kaneko-Ishino
T and Ishino F: Identification of an imprinted gene, Meg3/Gtl2 and
its human homologue MEG3, first mapped on mouse distal chromosome
12 and human chromosome 14q. Genes Cells. 5:211–220. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Zhou Y, Zhang X and Klibanski A: MEG3
noncoding RNA: A tumor suppressor. J Mol Endocrinol. 48:R45–R53.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Zhou Y, Zhong Y, Wang Y, Zhang X, Batista
DL, Gejman R, et al: Activation of p53 by MEG3 non-coding RNA. J
Biol Chem. 282:24731–24742. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Benetatos L, Hatzimichael E, Dasoula A,
Dranitsaris G, Tsiara S, Syrrou M, Georgiou I and Bourantas KL: CpG
methylation analysis of the MEG3 and SNRPN imprinted genes in acute
myeloid leukemia and myelodysplastic syndromes. Leuk Res.
34:148–153. 2010. View Article : Google Scholar
|
|
79
|
Durinck K, Goossens S, Peirs S, Wallaert
A, Van Loocke W, Matthijssens F, Pieters T, Milani G, Lammens T,
Rondou P, et al: Novel biological insights in T-cell acute
lymphoblastic leukemia. Exp Hematol. 43:625–639. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Zhang L, Xu HG and Lu C: A novel long
non-coding RNA T-ALL-R-LncR1 knockdown and Par-4 cooperate to
induce cellular apoptosis in T-cell acute lymphoblastic leukemia
cells. Leuk Lymphoma. 55:1373–1382. 2014. View Article : Google Scholar
|
|
81
|
Roussigne M, Cayrol C, Clouaire T, Amalric
F and Girard JP: THAP1 is a nuclear proapoptotic factor that links
prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies.
Oncogene. 22:2432–2442. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Zhang X, Weissman SM and Newburger PE:
Long intergenic non-coding RNA HOTAIRM1 regulates cell cycle
progression during myeloid maturation in NB4 human promyelocytic
leukemia cells. RNA Biol. 11:777–787. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Zhao H, Zhang X, Frazão JB, Condino-Neto A
and Newburger PE: HOX antisense lincRNA HOXA-AS2 is an apoptosis
repressor in all trans retinoic acid treated NB4 promyelocytic
leukemia cells. J Cell Biochem. 114:2375–2383. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Zhang X, Lian Z, Padden C, Gerstein MB,
Rozowsky J, Snyder M, Gingeras TR, Kapranov P, Weissman SM and
Newburger PE: A myelopoiesis-associated regulatory intergenic
noncoding RNA transcript within the human HOXA cluster. Blood.
113:2526–2534. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Walczak H, Miller RE, Ariail K, Gliniak B,
Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, et al:
Tumoricidal activity of tumor necrosis factor-related
apoptosis-inducing ligand in vivo. Nat Med. 5:157–163. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Sun J, Li W, Sun Y, Yu D, Wen X, Wang H,
Cui J, Wang G, Hoffman AR and Hu JF: A novel antisense long
noncoding RNA within the IGF1R gene locus is imprinted in
hematopoietic malignancies. Nucleic Acids Res. 42:9588–9601. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Chapuis N, Tamburini J, Cornillet-Lefebvre
P, Gillot L, Bardet V, Willems L, Park S, Green AS, Ifrah N,
Dreyfus F, et al: Autocrine IGF-1/IGF-1R signaling is responsible
for constitutive PI3K/Akt activation in acute myeloid leukemia:
Therapeutic value of neutralizing anti-IGF-1R antibody.
Haematologica. 95:415–423. 2010. View Article : Google Scholar :
|
|
88
|
Grandage VL, Gale RE, Linch DC and Khwaja
A: PI3-kinase/Akt is constitutively active in primary acute myeloid
leukaemia cells and regulates survival and chemoresistance via
NF-kappaB, Mapkinase and p53 pathways. Leukemia. 19:586–594.
2005.PubMed/NCBI
|
|
89
|
Girnita A, All-Ericsson C, Economou MA,
Aström K, Axelson M, Seregard S, Larsson O and Girnita L: The
insulin-like growth factor-I receptor inhibitor picropodophyllin
causes tumor regression and attenuates mechanisms involved in
invasion of uveal melanoma cells. Acta Ophthalmol. 86:26–34. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Delafontaine P, Song YH and Li Y:
Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1
binding proteins in blood vessels. Arterioscler Thromb Vasc Biol.
24:435–444. 2004. View Article : Google Scholar
|
|
91
|
Roy M, Sarkar R, Mukherjee A and Mukherjee
S: Inhibition of crosstalk between Bcr-Abl and PKC signaling by
PEITC, augments imatinib sensitivity in chronic myelogenous
leukemia cells. Chem Biol Interact. 242:195–201. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Heisterkamp N and Groffen J: Molecular
insights into the Philadelphia translocation. Hematol Pathol.
5:1–10. 1991.PubMed/NCBI
|
|
93
|
Bartram CR, de Klein A, Hagemeijer A, van
Agthoven T, Geurts van Kessel A, Bootsma D, Grosveld G,
Ferguson-Smith MA, Davies T, Stone M, et al: Translocation of c-ab1
oncogene correlates with the presence of a Philadelphia chromosome
in chronic myelocytic leukaemia. Nature. 306:277–280. 1983.
View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Cilloni D and Saglio G: Molecular
pathways: BCR-ABL. Clin Cancer Res. 18:930–937. 2012. View Article : Google Scholar
|
|
95
|
Guo G, Qiu X, Wang S, Chen Y, Rothman PB,
Wang Z, Chen Y, Wang G and Chen JL: Oncogenic E17K mutation in the
pleckstrin homology domain of AKT1 promotes v-Abl-mediated
pre-B-cell transformation and survival of Pim-deficient cells.
Oncogene. 29:3845–3854. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Yang J, Wang J, Chen K, Guo G, Xi R,
Rothman PB, Whitten D, Zhang L, Huang S and Chen JL: eIF4B
phosphorylation by pim kinases plays a critical role in cellular
transformation by Abl oncogenes. Cancer Res. 73:4898–4908. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Guo G, Kang Q, Zhu X, Chen Q, Wang X, Chen
Y, Ouyang J, Zhang L, Tan H, Chen R, et al: A long noncoding RNA
critically regulates Bcr-Abl-mediated cellular transformation by
acting as a competitive endogenous RNA. Oncogene. 34:1768–1779.
2015. View Article : Google Scholar
|
|
98
|
Dengler MA, Staiger AM, Gutekunst M,
Hofmann U, Doszczak M, Scheurich P, Schwab M, Aulitzky WE and van
der Kuip H: Oncogenic stress induced by acute hyper-activation of
Bcr-Abl leads to cell death upon induction of excessive aerobic
glycolysis. PLoS One. 6:e251392011. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Danisz K and Blasiak J: Role of
anti-apoptotic pathways activated by BCR/ABL in the resistance of
chronic myeloid leukemia cells to tyrosine kinase inhibitors. Acta
Biochim Pol. 60:503–514. 2013.PubMed/NCBI
|
|
100
|
Friesen C, Herr I, Krammer PH and Debatin
KM: Involvement of the CD95 (APO-1/FAS) receptor/ligand system in
drug-induced apoptosis in leukemia cells. Nat Med. 2:574–577. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Eichhorst ST, Müerköster S, Weigand MA and
Krammer PH: The chemotherapeutic drug 5-fluorouracil induces
apoptosis in mouse thymocytes in vivo via activation of the
CD95(APO-1/Fas) system. Cancer Res. 61:243–248. 2001.PubMed/NCBI
|
|
102
|
Yap KL, Li S, Muñoz-Cabello AM, Raguz S,
Zeng L, Mujtaba S, Gil J, Walsh MJ and Zhou MM: Molecular interplay
of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by
polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell.
38:662–674. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Iacobucci I, Sazzini M, Garagnani P,
Ferrari A, Boattini A, Lonetti A, Papayannidis C, Mantovani V,
Marasco E, Ottaviani E, et al: A polymorphism in the chromosome
9p21 ANRIL locus is associated to Philadelphia positive acute
lymphoblastic leukemia. Leuk Res. 35:1052–1059. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Zhang EB, Kong R, Yin DD, You LH, Sun M,
Han L, Xu TP, Xia R, Yang JS, De W, et al: Long noncoding RNA ANRIL
indicates a poor prognosis of gastric cancer and promotes tumor
growth by epigenetically silencing of miR-99a/miR-449a. Oncotarget.
5:2276–2292. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Korneev SA, Korneeva EI, Lagarkova MA,
Kiselev SL, Critchley G and O'Shea M: Novel noncoding antisense RNA
transcribed from human anti-NOS2A locus is differentially regulated
during neuronal differentiation of embryonic stem cells. RNA.
14:2030–2037. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Iacoangeli A, Lin Y, Morley EJ, Muslimov
IA, Bianchi R, Reilly J, Weedon J, Diallo R, Böcker W and Tiedge H:
BC200 RNA in invasive and preinvasive breast cancer.
Carcinogenesis. 25:2125–2133. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Chen W, Böcker W, Brosius J and Tiedge H:
Expression of neural BC200 RNA in human tumours. J Pathol.
183:345–351. 1997. View Article : Google Scholar
|
|
108
|
Sosińska P, Mikuła-Pietrasik J and Książek
K: The double-edged sword of long non-coding RNA: The role of human
brain-specific BC200 RNA in translational control,
neurodegenerative diseases, and cancer. Mutat Res Rev Mutat Res.
766:58–67. 2015. View Article : Google Scholar
|
|
109
|
Pickard MR, Mourtada-Maarabouni M and
Williams GT: Long non-coding RNA GAS5 regulates apoptosis in
prostate cancer cell lines. Biochim Biophys Acta. 1832:1613–1623.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Yin D, He X, Zhang E, Kong R, De W and
Zhang Z: Long noncoding RNA GAS5 affects cell proliferation and
predicts a poor prognosis in patients with colorectal cancer. Med
Oncol. 31:2532014. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Qiao HP, Gao WS, Huo JX and Yang ZS: Long
non-coding RNA GAS5 functions as a tumor suppressor in renal cell
carcinoma. Asian Pac J Cancer Prev. 14:1077–1082. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Lu X, Fang Y, Wang Z, Xie J, Zhan Q, Deng
X, Chen H, Jin J, Peng C, Li H, et al: Downregulation of gas5
increases pancreatic cancer cell proliferation by regulating CDK6.
Cell Tissue Res. 354:891–896. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Mourtada-Maarabouni M and Williams GT:
Role of GAS5 noncoding RNA in mediating the effects of rapamycin
and its analogues on mantle cell lymphoma cells. Clin Lymphoma
Myeloma Leuk. 14:468–473. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Chiyomaru T, Yamamura S, Fukuhara S,
Yoshino H, Kinoshita T, Majid S, Saini S, Chang I, Tanaka Y,
Enokida H, et al: Genistein inhibits prostate cancer cell growth by
targeting miR-34a and oncogenic HOTAIR. PLoS One. 8:e703722013.
View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Yan TH, Lu SW, Huang YQ, Que GB, Chen JH,
Chen YP, Zhang HB, Liang XL and Jiang JH: Upregulation of the long
noncoding RNA HOTAIR predicts recurrence in stage Ta/T1 bladder
cancer. Tumour Biol. 35:10249–10257. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Chiyomaru T, Fukuhara S, Saini S, Majid S,
Deng G, Shahryari V, Chang I, Tanaka Y, Enokida H, Nakagawa M, et
al: Long non-coding RNA HOTAIR is targeted and regulated by miR-141
in human cancer cells. J Biol Chem. 289:12550–12565. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Lee NK, Lee JH, Park CH, Yu D, Lee YC,
Cheong JH, Noh SH and Lee SK: Long non-coding RNA HOTAIR promotes
carcinogenesis and invasion of gastric adenocarcinoma. Biochem
Biophys Res Commun. 451:171–178. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Wu ZH, Wang XL, Tang HM, Jiang T, Chen J,
Lu S, Qiu GQ, Peng ZH and Yan DW: Long non-coding RNA HOTAIR is a
powerful predictor of metastasis and poor prognosis and is
associated with epithelial-mesenchymal transition in colon cancer.
Oncol Rep. 32:395–402. 2014.PubMed/NCBI
|
|
119
|
Wang CM, Wu QQ, Li SQ, Chen FJ, Tuo L, Xie
HW, Tong YS, Ji L, Zhou GZ, Cao G, et al: Upregulation of the long
non-coding RNA PlncRNA-1 promotes esophageal squamous carcinoma
cell proliferation and correlates with advanced clinical stage. Dig
Dis Sci. 59:591–597. 2014. View Article : Google Scholar
|
|
120
|
Cui Z, Ren S, Lu J, Wang F, Xu W, Sun Y,
Wei M, Chen J, Gao X, Xu C, et al: The prostate cancer-up-regulated
long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation
through reciprocal regulation of androgen receptor. Urol Oncol.
31:1117–1123. 2013. View Article : Google Scholar
|
|
121
|
Luo M, Li Z, Wang W, Zeng Y, Liu Z and Qiu
J: Upregulated H19 contributes to bladder cancer cell proliferation
by regulating ID2 expression. FEBS J. 280:1709–1716. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Barsyte-Lovejoy D, Lau SK, Boutros PC,
Khosravi F, Jurisica I, Andrulis IL, Tsao MS and Penn LZ: The c-Myc
oncogene directly induces the H19 noncoding RNA by allele-specific
binding to potentiate tumorigenesis. Cancer Res. 66:5330–5337.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Hibi K, Nakamura H, Hirai A, Fujikake Y,
Kasai Y, Akiyama S, Ito K and Takagi H: Loss of H19 imprinting in
esophageal cancer. Cancer Res. 56:480–482. 1996.PubMed/NCBI
|
|
124
|
Zhang EB, Han L, Yin DD, Kong R, De W and
Chen J: c-Myc-induced, long, noncoding H19 affects cell
proliferation and predicts a poor prognosis in patients with
gastric cancer. Med Oncol. 31:9142014. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Sun M, Xia R, Jin F, Xu T, Liu Z, De W and
Liu X: Downregulated long noncoding RNA MEG3 is associated with
poor prognosis and promotes cell proliferation in gastric cancer.
Tumour Biol. 35:1065–1073. 2014. View Article : Google Scholar
|
